NCT05218499 2026-03-02Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated LiposarcomaBoehringer IngelheimPhase 2/3 Completed400 enrolled 15 charts